Business ❯Pharmaceuticals ❯AbbVie ❯Acquisitions

Cerevel Therapeutics

AbbVie Acquires Cerevel Therapeutics for $8.7 Billion

AbbVie Acquires Neuroscience Biotech Cerevel for $8.7 Billion